A team of researchers from University Hospitals of North Midlands NHS Trust (UHNM), Keele University, and Loughborough University have developed a ground breaking blood test to detect lung cancer. "In ...

A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored. In a new study, the ‘Fourier Transform Infrared (FT-IR) microspectroscopy’ ...

A novel, blood-based test developed using fragmentomic features of cell-free DNA (cfDNA) detects colorectal cancer (CRC) with a 90.4% sensitivity and shows consistent performance across stages and ...

DUBAI, 21st November, 2025 (WAM) -- Sanad, the global aerospace engineering and asset management solutions leader wholly owned by Abu Dhabi’s sovereign investor, Mubadala Investment Company PJSC, has ...

Cyprus-based United Aerospace Maintenance Co. (UAMCO) has advanced its plans to move into full Leap engine overhauls after signing an agreement with Safran Test Cells to facilitate the construction of ...

Please provide your email address to receive an email when new articles are posted on . Low placental growth factor had a significant association with early-onset preeclampsia for women with sickle ...

UCI Health has opened a clinical trial to test an investigational cell therapy for lupus with the potential to give patients long-term remission of symptoms. One of the first California participants, ...

This article was originally published in Chalkbeat. Charles Longshore distinctly remembers the tipping point that led his Alabama middle school to ban cell phones, two years before the state adopted ...

LAFAYETTE PARISH — Two community health events are scheduled for Saturday, Sept. 13, at Brown Park in Lafayette, bringing together screenings, awareness, and free resources for local residents. The ...

In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...